Healthcare AI startup Heidi secures $26 million in Series A
Make us a preferred source
Make us a preferred source on Google
The news: Melbourne-based healthcare AI company Heidi has secured $US16.6 million ($26 million) in Series A follow-on funding to expand its AI 'medical scribe' technology.
The context: Heidi’s AI scribe operates during consultations, automating clinical note-taking and documentation so healthcare workers can focus on patient care. The company plans to expand its capabilities beyond scribing to include pre-chart summaries, clinical guideline access and patient engagement outside clinics.
The round was led by Headline, with participation from Local Globe, Anthology (Menlo Ventures and Anthropic) and existing investors Blackbird, HESTA, Possible Ventures and Archangel Ventures.
Major healthcare providers using Heidi include Modality Partnership in the UK, Beth Israel in Massachusetts, ForHealth in Australia and Tamaki Health in New Zealand.
The numbers: Heidi’s AI scribe now supports more than 1 million patient consultations weekly across five countries and has facilitated over 20 million patient interactions globally since launching in February 2024. The World Health Organisation projects a shortfall of 10 million health workers by 2030, while clinicians currently spend more than two hours per day on administrative tasks.
What they said: "Despite clinicians' passion for patient care and significant investment in their medical education, they are overwhelmed by an unsustainable administrative workload that drags them away from their clinical responsibilities," said Dr Thomas Kelly, CEO and co-founder of Heidi and former vascular surgical resident.
"Heidi's approach to the medical scribe market is truly differentiated. What sets Heidi apart are their bold choices: prioritising customisation over complex integrations, their global-first strategy, and building a product-led motion out of Australia that rivals tech giants like Canva and Atlassian," said Taylor Brandt, partner at Headline.
